NL-OMON53004招募中3 期
Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial. - COLOPEC 2
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 389
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Curative intent resection (R0/R1) of pT4N0-2M0 colon cancer, proximal rectal
- •cancer, or small bowel cancer, with or without adjuvant systemic therapy;
- •2. Age between 18 and 80 years;
- •3. Written informed consent.
排除标准
- •1. Histological subtype other than (mucinous) adenocarcinoma or signet-ring
- •cell carcinoma;
- •2. Clinical condition does not allow for second look DLS and subsequent
- •treatment of PM if detected;
- •3. Second look surgery thought not to be technically possible (i.e. because of
- •extensive abdominal surgery / re-interventions).
研究者
相似试验
进行中（未招募）
3 期
Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal MetastasesPeritoneal MetastasesColorectal CancerNCT03413254Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)389
尚未招募
3 期
Comparison of different Laparoscopic methods for gall bladder removalCTRI/2024/05/067740Datta Meghe Institute of Higher Education and Research
招募中
2 期
Phase II study of lAParoscopic colectomy for TRansverse and descending colon cancercolon cancerJPRN-UMIN000028746Aichi Cancer Center41
招募中
不适用
Relook Laparoscopy for Peritoneal Surface Disease (ReLaPSeD) TrialA prospective randomised controlled trial comparing relook laparoscopy vs. standard follow-up for early detection and treatment of patients at high risk for peritoneal metastases after resection of colorectal cancerColorectal cancer with high risk features for peritoneal metastasesCancer - Bowel - Back passage (rectum) or large bowel (colon)Surgery - Other surgeryACTRN12618000372280Surgical Outcome Research Centre194
进行中（未招募）
1 期
Quadratus lumborum 3 block (QLB3) for laparoscopic colorectal surgery: A double blind, prospective randomized placebo-controlled trial.EUCTR2019-002304-40-BEniversity Hospitals Leuven150